GENENTECH H-1B Visa Sponsorship & Salary Data

The median H-1B salary at GENENTECH is $129,584, based on 871 certified filings from FY 2020 to FY 2026. This is 8% higher than the national H-1B median salary of $120,000. Compensation at GENENTECH reflects their market positioning, with entry-level roles starting around $110,200 and senior positions reaching $177,300 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at GENENTECH range from $95,800 at the 10th percentile to $177,300 at the 90th percentile, showing a $81,500 spread across experience levels and roles. The 25th percentile is $110,200 and the 75th percentile is $152,984.

Yes, GENENTECH actively sponsors H-1B visas in FY 2026. In the most recent fiscal year (FY 2026), GENENTECH filed 136 H-1B labor condition applications with 130 certified and 0 denied, at a median salary of $140,213. Across FY 2020–2026, they have filed 926 total H-1B applications with 871 certified and a 0.1% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. GENENTECH sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), GENENTECH filed 136 H-1B applications, with 130 certified and 0 denied. Over 7 years of data, GENENTECH has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

GENENTECH's LCA (Labor Condition Application) denial rate is 0.1%, with 1 out of 926 applications denied across all years. This translates to a 99.9% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating GENENTECH as a potential H-1B sponsor.

This is an excellent approval rate, indicating GENENTECH has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

GENENTECH sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 871 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles GENENTECH most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at GENENTECH:

The most frequently sponsored role is Research Scientist with 151 filings at a median salary of $121,700. This is followed by Senior Research Scientist (45 filings) and Data Scientist.

GENENTECH's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where GENENTECH sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top GENENTECH H-1B locations:

The largest H-1B hub for GENENTECH is South San Francisco, CA with 736 filings at a median salary of $130,586. The highest-paying location is Boston, MA at $208,000 median. Salaries range from $102,981 to $208,000 across office locations.

GENENTECH's median H-1B salary has increased by +18% from FY 2020 ($118,581) to FY 2026 ($140,213). Tracking salary trends over time reveals how GENENTECH adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at GENENTECH.

Year-by-year breakdown:

• FY 2022: $122,600 (139 certified)
• FY 2023: $141,000 (113 certified)
• FY 2024: $141,500 (103 certified)
• FY 2025: $137,072 (136 certified)
• FY 2026: $140,213 (130 certified)

GENENTECH has maintained steady salary growth for H-1B positions over this period.

GENENTECH primarily files H-1B applications at Wage Level II, accounting for 32% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making GENENTECH's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 87% of positions at Level II or higher, GENENTECH typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

GENENTECH's median H-1B salary of $129,584 is 8% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating GENENTECH's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare GENENTECH's offerings with similar companies in your field for a more accurate assessment.

GENENTECH offers above-average H-1B compensation. Combined with their 871 certified filings and 0.1% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. GENENTECH's higher proportion of Level III-IV positions (55%) may benefit from wage-based lottery prioritization.

With 871 certified filings, GENENTECH invests significantly in H-1B sponsorship. The company's 0.1% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.